Adult Patient (≥ 18 years) with granulocytopenia (absolute number neutrophil: ≤500 / μl) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
Item
Adult Patient (>=18 years) with granulocytopenia (absolute number neutrophil: <=500 / ul) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
boolean
Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
Item
Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
boolean
Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
Item
Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
boolean
For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
Item
For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
boolean
Life expectancy ≥5 days
Item
Life expectancy ≥5 days
boolean
Treatment in one of said test centers
Item
Treatment in one of said test centers
boolean
Adequate renal and hepatic function in accordance with the following definitions
Item
Adequate renal and hepatic function in accordance with the following definitions
boolean
Bilirubin Total: ≤ 3x upper reference value
Item
Bilirubin Total: ≤ 3x upper reference value
boolean
SGOT or SGPT: ≤ 3x upper reference value
Item
SGOT or SGPT: ≤ 3x upper reference value
boolean
Alkaline phosphatase: ≤ 5x upper reference value
Item
Alkaline phosphatase: ≤ 5x upper reference value
boolean
Creatinine i. S.: ≤ 2x the upper reference value
Item
Creatinine i. S.: ≤ 2x the upper reference value
boolean
Written informed consent of the patient or the legal representative
Item
Written informed consent of the patient or the legal representative
boolean
Participate in this study at an earlier date
Item
Participate in this study at an earlier date
boolean
Serious psychiatric pre-/concomitant disease
Item
Serious psychiatric pre-/concomitant disease
boolean
Pregnancy or lactation
Item
Pregnancy or lactation
boolean
Women of childbearing age with insufficient or unsecured contraception
Item
Women of childbearing age with insufficient or unsecured contraception
boolean
Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
Item
Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
boolean
Patient with pathological function parameters of liver and kidney function
Item
Patient with pathological function parameters of liver and kidney function
boolean
Total bilirubin:> 3x upper reference value
Item
Total bilirubin:> 3x upper reference value
boolean
SGOT or SGPT:> 3x upper reference value
Item
SGOT or SGPT:> 3x upper reference value
boolean
Alkaline phosphatase:> 5x the upper reference value
Item
Alkaline phosphatase:> 5x the upper reference value
boolean
Creatinine i. S.:> 2x upper reference value
Item
Creatinine i. S.:> 2x upper reference value
boolean
Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
Item
Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
boolean
Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
Item
Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
boolean
Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
Item
Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
boolean
Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
Item
Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
boolean
Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
Item
Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
boolean
Missing or incomplete consent
Item
Missing or incomplete consent
boolean